CA-702

N/A

Report date: 2024/07/22 17:54:24
NME

Base Information

Drug NameCA-702
Drug Alias NameCA-702
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSjogren's Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCellAxia Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellAxia Inc
Inactive CompaniesN/A
Active IndicationsSjogren's Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A